Patents by Inventor Daniel Bond

Daniel Bond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS, METHODS, AND ARTICLES OF MANUFACTURE FOR PROVIDING FREQUENTLY PURCHASED ITEM RELOCATION INFORMATION TO CUSTOMERS
    Publication number: 20200311802
    Abstract: A method of operating a shopping notification system may include electronically recognizing a current presence of a customer at a store to provide recognized customer data. A database of previously purchased items of the customer may be accessed using the recognized customer data to provide frequently purchased items information associated with the customer. A category of items including any item in the frequently purchased items information may be determined to have moved within the store in a time between a previous presence of the customer at the store and the current presence of the customer at the store to provide item relocation information and the item relocation information may be electronically provided to the customer.
    Type: Application
    Filed: March 29, 2019
    Publication date: October 1, 2020
    Inventors: Susan Brosnan, Sue Copley, Gary Fails, Daniel Bond
  • Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors
    Patent number: 7825115
    Abstract: The disclosure relates to a cyclic urea compound of formula I: as defined herein, to the process for its preparation, pharmaceutical composition comprising it and its pharmaceutical use as an inhibitor on a protein kinase. Thus, the compound of formula I is useful for preventing or treating a physiological disorder capable of being modulated by inhibiting the activity of a protein kinase, such as a solid tumor.
    Type: Grant
    Filed: January 10, 2008
    Date of Patent: November 2, 2010
    Assignee: Aventis Pharma S.A.
    Inventors: Marcel Patek, Anil Nair, Augustin Hittinger, Conception Nemecek, Daniel Bond, Greg Harlow, Herve Bouchard, Jacques Mauger, Jean-Luc Malleron, Mark Palermo, Fahad Al-Obeidi, Thomas Faitg, Hartmut Strobel, Sven Ruf, Kurt Ritter, Youssef El-Ahmad, Dominique Lesuisse, Didier Bénard
  • Cyclic Urea Compounds, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors
    Publication number: 20080108654
    Abstract: The disclosure relates to a cyclic urea compound of formula I: as defined herein, to the process for its preparation, pharmaceutical composition comprising it and its pharmaceutical use as an inhibitor on a protein kinase. Thus, the compound of formula I is useful for preventing or treating a physiological disorder capable of being modulated by inhibiting the activity of a protein kinase, such as a solid tumor.
    Type: Application
    Filed: January 10, 2008
    Publication date: May 8, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Marcel PATEK, Anil NAIR, Augustin HITTINGER, Conception NEMECEK, Daniel BOND, Greg HARLOW, Herve BOUCHARD, Jacques MAUGER, Jean-Luc MALLERON, Mark PALERMO, Fahad AL-OBEIDI, Thomas FAITG, Hartmut STROBEL, Sven RUF, Kurt RITTER, Youssef EL-AHMAD, Dominique LESUISSE
  • Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
    Patent number: 7354933
    Abstract: The present invention relates to a cyclic urea compound of formula I: as defined herein. The invention is also directed to the process for its preparation, pharmaceutical composition comprising it and its pharmaceutical use, as an inhibitor on a protein kinase. Thus, it is useful for preventing or treating a physiological disorder capable of being modulated by inhibiting the activity of a protein kinase, such as a solid tumor.
    Type: Grant
    Filed: February 2, 2004
    Date of Patent: April 8, 2008
    Assignee: Aventis Pharma SA
    Inventors: Marcel Patek, Anil Nair, Augustin Hittinger, Conception Nemecek, Daniel Bond, Greg Harlow, Herve Bouchard, Jacques Mauger, Jean-Luc Malleron, Mark Palermo, Fahad Al-Obeidi, Thomas Faitg, Hartmut Strobel, Sven Ruf, Kurt Ritter, Youssef El-Ahmad, Dominique Lesuisse, Didier Bénard
  • Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
    Publication number: 20040248884
    Abstract: The present invention relates to a cyclic urea compound of formula I: 1
    Type: Application
    Filed: February 2, 2004
    Publication date: December 9, 2004
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Marcel Patek, Anil Nair, Augustin Hittinger, Conception Nemecek, Daniel Bond, Greg Harlow, Herve Bouchard, Jacques Mauger, Jean-Luc Malleron, Mark Palermo, Fahad Al-Obeidi, Thomas Faitg, Hartmut Strobel, Sven Ruf, Kurt Ritter, Youssef El-Ahmad, Dominique Lesuisse